TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 122 filers reported holding TG THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,001,493 | +32.2% | 168,718 | +13.0% | 0.00% | 0.0% |
| Q1 2024 | $2,270,184 | -9.6% | 149,256 | +1.5% | 0.00% | 0.0% |
| Q4 2023 | $2,512,434 | +121.4% | 147,098 | +8.4% | 0.00% | – |
| Q3 2023 | $1,134,570 | -65.8% | 135,714 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $3,313,631 | +77.5% | 133,399 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $1,867,020 | +38.4% | 124,137 | +8.8% | 0.00% | 0.0% |
| Q4 2022 | $1,349,235 | +83.3% | 114,052 | -8.3% | 0.00% | – |
| Q3 2022 | $736,000 | +22.9% | 124,356 | -11.8% | 0.00% | – |
| Q2 2022 | $599,000 | -42.5% | 140,981 | +28.8% | 0.00% | – |
| Q1 2022 | $1,041,000 | -49.9% | 109,452 | +0.1% | 0.00% | -100.0% |
| Q4 2021 | $2,078,000 | -42.7% | 109,371 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $3,629,000 | +17.9% | 109,043 | +37.5% | 0.00% | 0.0% |
| Q2 2021 | $3,077,000 | -17.7% | 79,304 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $3,740,000 | -4.1% | 77,593 | +3.5% | 0.00% | -50.0% |
| Q4 2020 | $3,899,000 | +137.0% | 74,948 | +21.9% | 0.00% | +100.0% |
| Q3 2020 | $1,645,000 | +260.0% | 61,458 | +161.8% | 0.00% | – |
| Q2 2020 | $457,000 | +114.6% | 23,475 | +8.3% | 0.00% | – |
| Q1 2020 | $213,000 | -24.2% | 21,675 | -14.5% | 0.00% | – |
| Q4 2019 | $281,000 | +136.1% | 25,359 | +19.9% | 0.00% | – |
| Q3 2019 | $119,000 | -22.2% | 21,156 | +19.6% | 0.00% | – |
| Q2 2019 | $153,000 | +86.6% | 17,682 | +73.6% | 0.00% | – |
| Q1 2019 | $82,000 | +95.2% | 10,185 | 0.0% | 0.00% | – |
| Q4 2018 | $42,000 | -26.3% | 10,185 | 0.0% | 0.00% | – |
| Q3 2018 | $57,000 | -53.3% | 10,185 | +9.6% | 0.00% | – |
| Q2 2018 | $122,000 | -10.3% | 9,291 | -2.9% | 0.00% | – |
| Q1 2018 | $136,000 | +19.3% | 9,566 | -29.4% | 0.00% | – |
| Q4 2017 | $114,000 | -23.0% | 13,559 | +8.5% | 0.00% | – |
| Q3 2017 | $148,000 | +29.8% | 12,500 | +11.0% | 0.00% | – |
| Q2 2017 | $114,000 | +0.9% | 11,264 | +14.9% | 0.00% | – |
| Q1 2017 | $113,000 | +156.8% | 9,801 | +4.1% | 0.00% | – |
| Q4 2016 | $44,000 | -8.3% | 9,417 | +50.0% | 0.00% | – |
| Q3 2016 | $48,000 | +11.6% | 6,278 | -12.6% | 0.00% | – |
| Q2 2016 | $43,000 | -33.8% | 7,185 | 0.0% | 0.00% | – |
| Q1 2016 | $65,000 | +18.2% | 7,185 | +54.4% | 0.00% | – |
| Q4 2015 | $55,000 | +19.6% | 4,653 | 0.0% | 0.00% | – |
| Q3 2015 | $46,000 | -38.7% | 4,653 | 0.0% | 0.00% | – |
| Q2 2015 | $75,000 | 0.0% | 4,653 | 0.0% | 0.00% | – |
| Q1 2015 | $75,000 | -1.3% | 4,653 | 0.0% | 0.00% | – |
| Q4 2014 | $76,000 | +52.0% | 4,653 | 0.0% | 0.00% | – |
| Q3 2014 | $50,000 | – | 4,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
| M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
| Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
| Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
| Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
| 683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
| Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
| Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
| Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
| Artal Group S.A. | 511,389 | $7,691 | 0.46% |